Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic Cancer
Recruiting · NCT06144762 · Interventional (participants receive a specific treatment) · Lead sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Specifically, in this project, the objective will be developped a model to capture imaging-based tumor heterogeneity with multiscale radiomics approach by obtaining the mirror tumor image at in vivo MRI, ex vivo MRI at histology. This imaging model giving a perfect virtual histology tumor representation will be secondary implemented on routine in vivo clinical MRI for early cancer detection and treatment monitoring. Successful completion of this proposal will lead to a comprehensive non invasive characterisation of pancreatic cancer and will be a game changer in patient management.
Who can take part
Inclusion criteria
- Patient aged \>18 2.
- Pathologically proven pancreatic cancer which can beneficiate of upfront surgery or delayed surgery followed by neoadjuvant chemotherapy.
- Negative pregnancy test for women of childbearing potential
- Patients affiliated to a social protection system
- Written informed consent signed before project onset.
Exclusion criteria
- presence of metastases,
- Patient who will not have surgery
- Pregnant or breastfeeding women
- Mental or psychological state, physical or legal incapacity preventing participation in the project.
Where it is running
1 location listed.
- NOUGARET Stephanie - Montpellier, France